Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Strategies for AIDS vaccines

E J Stott1, G C Schild

  • 1National Institute for Biological Standards and Control Potters Bar, Hertfordshire, UK.

The Journal of Antimicrobial Chemotherapy
|May 1, 1996
PubMed
Summary

Developing an AIDS vaccine faces challenges, but progress is being made. Research explores inactivated, live attenuated, and subunit vaccines, with animal models proving crucial for understanding immune responses and guiding human immunodeficiency virus (HIV) vaccine strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Virological studies in chronic bronchitis.

British medical journal·2010
Same author

Preparation and characterization of new challenge stocks of SIVmac32H J5 following rapid serial passage of virus in vivo.

Journal of medical primatology·2007
Same author

Preparation of vaccines against H5N1 influenza.

Vaccine·2002
Same author

Clinical safety issues of measles, mumps and rubella vaccines.

Bulletin of the World Health Organization·2000
Same author

Vaccines against H5N1 influenza.

Vaccine·2000
Same author

Construction of infectious SIV/HIV-2 chimeras.

AIDS (London, England)·2000

Area of Science:

  • Immunology
  • Vaccinology
  • Epidemiology

Background:

  • The global AIDS epidemic disproportionately affects young people, with millions of human immunodeficiency virus (HIV) infections projected to increase.
  • A safe and effective HIV vaccine is crucial for controlling the epidemic, yet its development is complex.

Purpose of the Study:

  • To review the progress and challenges in developing an effective vaccine against HIV.
  • To explore various vaccine strategies, including inactivated, live attenuated, and subunit approaches.

Main Methods:

  • Utilizing animal models, particularly simian immunodeficiency virus (SIV) infection in macaques, to study vaccine efficacy.
  • Analyzing immune responses generated by different vaccine candidates in preclinical and clinical settings.

Main Results:

  • Inactivated vaccines showed protection in models, but antibodies targeted cellular proteins, offering alternative strategies.
  • Live attenuated vaccines, initially deemed hazardous, now show potent protection in models, prompting mechanistic studies.
  • Subunit vaccines are safe and antigenic in humans, but induced antibodies show limited neutralization of circulating HIV strains.

Conclusions:

  • Multiple vaccine approaches, including inactivated, live attenuated, and subunit vaccines, are under active investigation.
  • Understanding mechanisms of protection from SIV models is key to developing safer and more effective HIV vaccines.
  • Overcoming challenges in inducing durable and broadly neutralizing antibodies is critical for successful HIV vaccine development.

Related Experiment Videos